Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 38 for “"PCV13"”.

  1. Defining the paediatric nasopharyngeal microbiota during PCV13 vaccine implementation

    … and expands upon this area of work, focusing on PCV13 implementation, which occurred four years after the introduction of PCV7, and its effects on pneumococcal carriage and other species carried in the upper respiratory tract.<br/><br/>Between 2006/07 and 2012/13, PCV13 vaccine serotypes reduced …

    soton Download PDF for Defining the paediatric nasopharyngeal microbiota during PCV13 vaccine implementation (opens in a new tab)

  2. Pneumococcal carriage and disease during the implementation of PCV13: 2006 to 2016

    … of a 13-valent pneumococcal conjugate vaccine (PCV13) allows the impact of the vaccine to be assessed and may provide information with which to inform public health policies.<br/><br/><i>Streptococcus pneumoniae</i> isolated from the nasopharynx of healthy children were collected alongside …

    soton Download PDF for Pneumococcal carriage and disease during the implementation of PCV13: 2006 to 2016 (opens in a new tab)

  3. INVASIVE PNEUMOCOCCAL DISEASE RISK IN U.S. ADULTS AND IMPLICATIONS FOR FUTURE PNEUMOCOCCAL VACCINE STRATEGY

    … Since 13-valent pneumococcal conjugate vaccine (PCV13) was recommended for children (2010) and adults aged ≥65 years (2014), adult pneumococcal vaccine recommendations have been updated multiple times, and the COVID-19 pandemic disrupted IPD trends. Assessment of these interventions by adult …

    jhu Repository record for INVASIVE PNEUMOCOCCAL DISEASE RISK IN U.S. ADULTS AND IMPLICATIONS FOR FUTURE PNEUMOCOCCAL VACCINE STRATEGY (opens in a new tab) Embargoed until 2030-05-01

  4. Health and economic impact of the 13-valent pneumococcal conjugate vaccination program in British Columbia, Canada

    … the 13-valent pneumococcal conjugate vaccine (PCV13) for children. This thesis evaluated changes in health and economic burden from pneumococcal disease following the PCV13 introduction in the infant immunization program in British Columbia (BC), Canada. METHODS: A literature search and …

    ubc Repository record for Health and economic impact of the 13-valent pneumococcal conjugate vaccination program in British Columbia, Canada (opens in a new tab) Download PDF for Health and economic impact of the 13-valent pneumococcal conjugate vaccination program in British Columbia, Canada (opens in a new tab)

  5. DIFFERENCES IN PNEUMOCOCCAL ANTIMICROBIAL RESISTANCE PATTERNS BETWEEN VACCINE AND NON-VACCINE SEROTYPES AMONG CHILDREN IN INDIA

    … pneumoniae. In India, phased, regional PCV13 introduction began in 2017. Understanding antibiotic susceptibility profiles of prevalent serotypes is important for monitoring potential changes following PCV introduction. Methods: Between October 2020 and November 2022, nasopharyngeal swabs …

    jhu Repository record for DIFFERENCES IN PNEUMOCOCCAL ANTIMICROBIAL RESISTANCE PATTERNS BETWEEN VACCINE AND NON-VACCINE SEROTYPES AMONG CHILDREN IN INDIA (opens in a new tab)

  6. Pneumococcal vaccination in inflammatory rheumatic disease and in splenectomy patients. From antibody response to memory cells.

    … were invited to receive one dose 13-valent PCV (PCV13). Blood was drawn before and 4-6 weeks after PCV13. Serotype-specific antibody responses were determined using a multiplex fluorescent microsphere immunoassay (MFMI). (II and III) Consecutive patients with systemic vasulitis, rheumatoid …

    lund Repository record for Pneumococcal vaccination in inflammatory rheumatic disease and in splenectomy patients. From antibody response to memory cells. (opens in a new tab) Download PDF for Pneumococcal vaccination in inflammatory rheumatic disease and in splenectomy patients. From antibody response to memory cells. (opens in a new tab)

  7. Invasive Pneumokokken-Erkrankung im Kindesalter: Herausforderungen in der Ära des 13-valenten Konjugatimpfstoffs

    … 13-valenten Pneumokokken-Konjugatimpfstoff (PCV13) ersetzt. In dieser kumulativen Dissertation werden die folgenden Aspekte untersucht: 1.) Inzidenz von IPE in Deutschland bei Kindern mit Grunderkrankungen und Identifikation einer adäquaten Impfstrategie 2.) Vergleich der Impfstoffwirksamkeit …

    lmu-germany Repository record for Invasive Pneumokokken-Erkrankung im Kindesalter: Herausforderungen in der Ära des 13-valenten Konjugatimpfstoffs (opens in a new tab)

  8. Φορεία πνευμονιόκοκκου στην Κύπρο σε υγιή παιδιά 6 - 36 μηνών

    … Among 1105 children enrolled, 393 had received PCV13 and 685 PCV10. The prevailing isolated serotypes were: 23A (14.3%), 15A (8.9%), 6C (8.6%), 23B (7.5%), 19A (5.4%) and 15B (5%). The proportion of non-vaccine serotypes, PCV10 serotypes, PCV13 additional serotypes (3, 6A, 19A) was 76.8%, 2.1% …

    greece Repository record for Φορεία πνευμονιόκοκκου στην Κύπρο σε υγιή παιδιά 6 - 36 μηνών (opens in a new tab)

  9. Effect of pneumococcal conjugate vaccine dosing schedules on invasive pneumococcal disease in children

    … pneumococcal conjugate vaccines (PCV7 and PCV13, respectively) have significantly reduced the burden of invasive pneumococcal disease (IPD) in children. This thesis evaluated the effect of different PCV dosing schedules in children under 18 following their introduction in the infant …

    ubc Repository record for Effect of pneumococcal conjugate vaccine dosing schedules on invasive pneumococcal disease in children (opens in a new tab) Download PDF for Effect of pneumococcal conjugate vaccine dosing schedules on invasive pneumococcal disease in children (opens in a new tab)

  10. Selection and Evolution of Pneumococci in Response to Conjugate Vaccines

    … The 13-valent pneumococcal conjugate vaccine (PCV13) was introduced in the United States in 2010 for the prevention of invasive pneumococcal disease (IPD) and otitis media and was released without efficacy data. In this study we set out to 1) determine potential efficacy for invasive and …

    uab Repository record for Selection and Evolution of Pneumococci in Response to Conjugate Vaccines (opens in a new tab)

  11. Evaluating the impact of pneumococcal conjugate vaccines on childhood disease burden and antibiotic use: evidence from the United Kingdom and Sub-Saharan Africa

    … review summarised existing research on PCV13 effectiveness in reducing childhood IPD incidence and all-cause mortality. Three population-based studies were then conducted: (i) an interrupted time series analysis using IQVIA Medical Research Data (IMRD) from 2008–2019 to assess the impact …

    qu-belfast Repository record for Evaluating the impact of pneumococcal conjugate vaccines on childhood disease burden and antibiotic use: evidence from the United Kingdom and Sub-Saharan Africa (opens in a new tab) Embargoed until 2028-07-31

  12. Early immune priming and activation against Streptococcus pneumoniae from maternal vaccination.

    … could be due to vaccines such as Prevnar13 (PCV13) not being administered until the infant is 8 weeks old. Access to vaccination is limited in LMIC and some children might not receive vaccinations. Therefore, in children, there is a window of susceptibility to this infection that could be …

    birmingham Download PDF for Early immune priming and activation against Streptococcus pneumoniae from maternal vaccination. (opens in a new tab)

  13. Η επίδραση του εμβολιασμού με τα συζευγμένα εμβόλια κατά του πνευμονιόκοκκου στην επιδημιολογία της πνευμονίας που επιπλέκεται με παραπνευμονική συλλογή (που απαιτεί παροχέτευση)

    … συζευγμένου πνευμονιοκοκκικού εμβολίου (PCV13) αναμένεται να παρέχει σημαντική προστασία έναντι των ΠΣ. Η παρούσα μελέτη έχει στόχο τη μελέτη της επίδρασης του εμβολιασμού με PCV7 και PCV13 στην επιδημιολογία των ΠΣ στην παιδική ηλικία. Μέθοδος: Πρόκειται για πολυκεντρική μελέτη …

    athens Repository record for Η επίδραση του εμβολιασμού με τα συζευγμένα εμβόλια κατά του πνευμονιόκοκκου στην επιδημιολογία της πνευμονίας που επιπλέκεται με παραπνευμονική συλλογή (που απαιτεί παροχέτευση) (opens in a new tab)

  14. The Economic Evaluation of Adult Immunization Programs: The Importance of Local Context and the Example of Pneumococcal Vaccination

    … the 13-valent pneumococcal conjugate vaccine (PCV13) for older adults (65+). Streptococcus pneumoniae is a gram-positive bacterium that represents one of the most common causes of community-acquired pneumonia (CAP), imposing a significant health and financial burden across the world. Due to the …

    toronto-retro Repository record for The Economic Evaluation of Adult Immunization Programs: The Importance of Local Context and the Example of Pneumococcal Vaccination (opens in a new tab)

  15. Χαρακτηριστικά του Στρεπτοκόκκου της πνευμονίας που αποικίζει τον παιδικό πληθυσμό Λεμεσού και Πάφου σε περίοδο υψηλής εμβολιαστικής κάλυψης με τα εμβόλια PCV10 και PCV13: ορότυποι και αντοχή στα αντιβιοτικά

    … Πάφου μετά την ευρεία εφαρμογή του PCV10 και του PCV13. Μέθοδος: Λήφθηκαν 299 δείγματα από τον οπίσθιο ρινοφάρυγγα υγιών παιδιών ηλικίας 6 έως 72 μηνών, το διάστημα Δεκέμβριο 2023 - Μάϊο 2024, τα οποία καλλιεργήθηκαν σε κατάλληλα θρεπτικά υλικά. Στη συνέχεια ελέγχθηκε η ευαισθησία στα αντιβιοτικά …

    athens Repository record for Χαρακτηριστικά του Στρεπτοκόκκου της πνευμονίας που αποικίζει τον παιδικό πληθυσμό Λεμεσού και Πάφου σε περίοδο υψηλής εμβολιαστικής κάλυψης με τα εμβόλια PCV10 και PCV13: ορότυποι και αντοχή στα αντιβιοτικά (opens in a new tab)

  16. Relative importance of S. pneumoniae serotypes causing invasive pneumococcal disease in young children after the introduction of conjugate vaccines

    … Results: The introduction of highly valent PCVs (PCV13 and/or PCV10) has resulted in a consistent reduction of IPD incidence among young children. The decreases in the incidence of IPD have been driven by declines of cases due to vaccine-targeted serotypes. Less consistently, there is evidence of …

    edinburgh Repository record for Relative importance of S. pneumoniae serotypes causing invasive pneumococcal disease in young children after the introduction of conjugate vaccines (opens in a new tab)

  17. The impact of pneumococcal conjugate vaccines on serotype prevalence, proportion, and antibiotic susceptibility of streptococcus pneumoniae among children 0 to 84 months from 2004 through 2023 at Boston Medical Center

    … of pneumococci by serotype grouping [PCV7, PCV13 unique + 6C, PCV20-additional, and nonvaccine serotypes and individual serotypes were analyzed for each study. A composite analysis of the data was created for the 20-year period. Comparing prevalence and proportion of pneumococci by serotype …

    bu Repository record for The impact of pneumococcal conjugate vaccines on serotype prevalence, proportion, and antibiotic susceptibility of streptococcus pneumoniae among children 0 to 84 months from 2004 through 2023 at Boston Medical Center (opens in a new tab)

  18. Μελέτη της επιδημιολογίας και μικροβιολογίας της βακτηριακής οξείας μέσης ωτίτιδας με ωτόρροια στην εποχή των συζευγμένων πνευμονιοκοκκικών εμβολίων σε ένα τριτοβάθμιο παιδιατρικό νοσοκομείο της Αττικής

    … εμβόλιο(PCV7) αντικαταστάθηκε από το 13-δύναμο(PCV13). Στόχος της μελέτης είναι η διερεύνηση της επίδρασης του εμβολιασμού στην επιδημιολογία της ΟΜΩΩ στην Αττική. Μέθοδος: Καταγράφηκαν οι καλλιέργειες ωτικού εκκρίματος παιδιών με ΟΜΩΩ στο Νοσοκομείο Παίδων «Π.&Α. Κυριακού» το 2007-2019. …

    athens Repository record for Μελέτη της επιδημιολογίας και μικροβιολογίας της βακτηριακής οξείας μέσης ωτίτιδας με ωτόρροια στην εποχή των συζευγμένων πνευμονιοκοκκικών εμβολίων σε ένα τριτοβάθμιο παιδιατρικό νοσοκομείο της Αττικής (opens in a new tab)

Page 1 of 2